Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.

Details

Ressource 1Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
Serval ID
serval:BIB_A7BA8C35583C
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Angiotensin-converting enzyme and dipeptidyl peptidase IV inhibitors: an increased risk of angioedema.
Journal
Hypertension
Author(s)
Grouzmann E., Livio F., Buclin T.
ISSN
0194-911X
Publication state
Published
Issued date
2009
Peer-reviewed
Oui
Volume
54
Number
3
Pages
468-470
Language
english
Notes
Publication types: Comment ; Editorial - Publication Status: ppublish
Keywords
adamantane/adverse effects , adamantane/analogs & derivatives , angioedema/chemically induced , angiotensin-converting enzyme inhibitors/adverse effects , antigens , CD26/antagonists & inhibitors , antigens , CD26/metabolism , dipeptidyl-peptidase IV inhibitors/adverse effects , drug synergism , humans , models , biological , nitriles/adverse effects , pyrrolidines/adverse effects , risk factors
Pubmed
Web of science
Open Access
Yes
Create date
07/10/2009 15:40
Last modification date
20/08/2019 15:12
Usage data